Evidence map›Paper›PMID 27467440›Full record

ArticleJAMA oncology2016

Association Between Germline Mutation in VSIG10L and Familial Barrett Neoplasia.

Ryan E Fecteau, Jianping Kong, Adam Kresak, Wendy Brock, Yeunjoo Song, Hisashi Fujioka, Robert Elston, Joseph E Willis, John P Lynch, Sanford D Markowitz and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in JAMA oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Esophageal cancer: from pathogenesis to precision therapies.Signal transduction and targeted therapy · 2026
    Review
  2. Article
  3. Pathogenesis of Barrett's Esophagus: Evolving and Emerging Mechanisms.Gastrointestinal endoscopy clinics of North America · 2026
    Review
  4. Article
  5. Review
  6. Review
  7. Improving outcomes in patients with oesophageal cancer.Nature reviews. Clinical oncology · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Global burden and epidemiology of Barrett oesophagus and oesophageal cancer.Nature reviews. Gastroenterology & hepatology · 2021
    Review
  13. Article
  14. Association of sporadic and familial Barrett's esophagus with breast cancer.Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus · 2018
    Article
  15. Genomics, Endoscopy, and Control of Gastroesophageal Cancers: A Perspective.Cellular and molecular gastroenterology and hepatology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Ryan E FecteauDepartment of Pathology, Case Medical Center, Case Western Reserve University, Cleveland, Ohio.
Jianping KongDivision of Gastroenterology, Department of Medicine, University of Pennsylvania, Philadelphia.
Adam KresakDepartment of Pathology, Case Medical Center, Case Western Reserve University, Cleveland, Ohio.
Wendy BrockDivision of Gastroenterology and Liver Disease, Department of Medicine, Case Medical Center, Cleveland, Ohio.
Yeunjoo SongDepartment of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, Ohio.
Hisashi FujiokaElectron Microscopy Facility, Case Western Reserve University, Cleveland, Ohio.
Robert ElstonDepartment of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, Ohio6Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio.
Joseph E WillisDepartment of Pathology, Case Medical Center, Case Western Reserve University, Cleveland, Ohio6Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio.
John P LynchDivision of Gastroenterology, Department of Medicine, University of Pennsylvania, Philadelphia.
Sanford D MarkowitzCase Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio7Division of Hematology-Oncology, Department of Medicine, Case Western Reserve University, Cleveland, Ohio8Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, Ohio.
Kishore GudaCase Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio9Division of General Medical Sciences-Oncology, Case Western Reserve University, Cleveland, Ohio.
Amitabh ChakDivision of Gastroenterology and Liver Disease, Department of Medicine, Case Medical Center, Cleveland, Ohio6Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio.
Case Western Reserve University · USUniversity of Pennsylvania · USUniversity Hospitals Case Medical Center · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007250 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI HUANG, ALEX YEE-CHEN · 1985 to 2023
$33.4M
Targeting 15-PGDH in Colon Cancer Prognosis, Prediction, Treatment and PreventionP50CA150964 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI MARKOWITZ, SANFORD D. · 2011 to 2022
$24.6M
The Cleveland Digestive Diseases Research Core Center (DDRCC)P30DK097948 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI Fabio Cominelli · 2015 to 2026
$15.6M
Whole Exome Approaches for Esophageal Adenocarcinoma Susceptibility GenesU54CA163060 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI CHAK, AMITABH, GUDA, KISHORE · 2011 to 2022
$14.0M
Weight loss-induced Microbiome and Adipokine Changes in Barrett's EsophagusU54CA163004 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ABRAMS, JULIAN, RUSTGI, ANIL K · 2011 to 2022
$12.5M
Mouse models for esophageal Cox-2 oxidative stress and DNA damageK26OD012097 · OD · UNIVERSITY OF PENNSYLVANIA · PI LYNCH, JOHN P. · 2013 to 2017
$737k
Novel O-glycosylation Gene Mutations in Colon CancerK08CA148980 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI GUDA, KISHORE · 2010 to 2014
$682k
NCI NIH HHS K08 CA148980NCI NIH HHS P50 CA150964NCI NIH HHS U54 CA163004NCI NIH HHS U54 CA163060NIDDK NIH HHS P30 DK097948NIGMS NIH HHS T32 GM007250NIH HHS K26 OD012097
6 · The paper itself

Abstract

importanceEsophageal adenocarcinoma and its precursor lesion Barrett esophagus have seen a dramatic increase in incidence over the past 4 decades yet marked genetic heterogeneity of this disease has precluded advances in understanding its pathogenesis and improving treatment.

objectiveTo identify novel disease susceptibility variants in a familial syndrome of esophageal adenocarcinoma and Barrett esophagus, termed familial Barrett esophagus, by using high-throughput sequencing in affected individuals from a large, multigenerational family. DESIGN, SETTING, AND

participantsWe performed whole exome sequencing (WES) from peripheral lymphocyte DNA on 4 distant relatives from our multiplex, multigenerational familial Barrett esophagus family to identify candidate disease susceptibility variants. Gene variants were filtered, verified, and segregation analysis performed to identify a single candidate variant. Gene expression analysis was done with both quantitative real-time polymerase chain reaction and in situ RNA hybridization. A 3-dimensional organotypic cell culture model of esophageal maturation was utilized to determine the phenotypic effects of our gene variant. We used electron microscopy on esophageal mucosa from an affected family member carrying the gene variant to assess ultrastructural changes. MAIN OUTCOMES AND MEASURES: Identification of a novel, germline disease susceptibility variant in a previously uncharacterized gene.

resultsA multiplex, multigenerational family with 14 members affected (3 members with esophageal adenocarcinoma and 11 with Barrett esophagus) was identified, and whole-exome sequencing identified a germline mutation (S631G) at a highly conserved serine residue in the uncharacterized gene VSIG10L that segregated in affected members. Transfection of S631G variant into a 3-dimensional organotypic culture model of normal esophageal squamous cells dramatically inhibited epithelial maturation compared with the wild-type. VSIG10L exhibited high expression in normal squamous esophagus with marked loss of expression in Barrett-associated lesions. Electron microscopy of squamous esophageal mucosa harboring the S631G variant revealed dilated intercellular spaces and reduced desmosomes. CONCLUSIONS AND RELEVANCE: This study presents VSIG10L as a candidate familial Barrett esophagus susceptibility gene, with a putative role in maintaining normal esophageal homeostasis. Further research assessing VSIG10L function may reveal pathways important for esophageal maturation and the pathogenesis of Barrett esophagus and esophageal adenocarcinoma.

Indexed as

AdenocarcinomaAdultAgedAmino Acid SequenceAntigens, NeoplasmBarrett EsophagusCells, CulturedEpithelial CellsEsophageal NeoplasmsFemaleGenetic Association StudiesGenetic Predisposition to DiseaseGerm-Line MutationHumansMaleMembrane GlycoproteinsAntigens, NeoplasmMembrane GlycoproteinsVSIG1 protein, human

Identifiers

PMID27467440
PMCPMC5063702
OpenAlexW2479814393

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.